Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Myeloproliferative Disorders × Practice Guidelines as Topic × Clear all

Sponsor

Conditions

Breast Neoplasms 4 Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Urinary Bladder Neoplasms 2 Rectal Neoplasms 2 Neoplasms 2 Colorectal Neoplasms 2 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Sarcoma 1 Recurrence 1 Radiodermatitis 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Multiple Endocrine Neoplasia Type 1 1 Melanoma 1 Lung Neoplasms 1 Localized Prostate Carcinoma 1 Leukemia, Myeloid, Acute 1 Hepatitis B 1 Hematologic Neoplasms 1 Gastrointestinal Neoplasms 1 Esophageal Neoplasms 1 Endometrial Clear Cell Adenocarcinoma 1 Disease Progression 1 Digestive System Carcinoma 1 Communication 1 Colonic Neoplasms 1 Carcinoma, Renal Cell 1

Interventions

fludarabine phosphate 36 Whole-Body Irradiation 29 Mycophenolic Acid 27 Cyclophosphamide 26 Peripheral Blood Stem Cell Transplantation 24 Tacrolimus 21 Busulfan 18 Antilymphocyte Serum 18 fludarabine 16 Cyclosporine 14 ruxolitinib 13 Melphalan 13 Cytarabine 11 Methotrexate 10 thymoglobulin 9 Etoposide 9 Sirolimus 8 Filgrastim 7 Cyclosporins 7 Rituximab 6 Granulocyte Colony-Stimulating Factor 6 Cord Blood Stem Cell Transplantation 6 Radiotherapy 5 Alemtuzumab 5 ponatinib 4 Flow Cytometry 4 Azacitidine 4 Stem Cell Transplantation 3 Methylprednisolone 3 Mesna 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡